- Report
- May 2025
- 50 Pages
Global
From €2428EUR$2,650USD£2,063GBP
The Sulbentine market is a segment of the dermatological drugs industry. It is composed of products used to treat skin conditions such as eczema, psoriasis, and dermatitis. These products are typically topical creams, ointments, and lotions that contain active ingredients such as corticosteroids, calcineurin inhibitors, and vitamin D analogues. These products are used to reduce inflammation, itching, and redness associated with skin conditions.
The Sulbentine market is highly competitive, with many companies offering a variety of products. Some of the major players in the market include GlaxoSmithKline, Pfizer, Novartis, Sanofi, and Johnson & Johnson. Other companies include Galderma, Mylan, and Sun Pharmaceuticals. Show Less Read more